Xarelto® Dosing Guide

Dosing Guide

Dosage Instructions

Xarelto 2.5 mg can be taken with or without food.

* Not recommended in patients with CrCl <15 ml/min; use with caution in patients with CrCl 15-29 ml/min and in patients with CrCl 30-49 ml/min when concomitantly receiving medicinal products that increase rivaroxaban plasma concentration.

PP-XAR-UA-0622-1_13 Dec 2022

References

Xarelto^® (rivaroxaban) Summary of Product Characteristics. Xarelto^® (rivaroxaban) Summary of Product Characteristics. Return to content

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA and UK.

Last updated on 26/12/2019

Xarelto® Dosing Guide

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease1

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease 1

Dosage Instructions

References

If you would prefer to visit your local website, please select your country:

Xarelto® Dosing Guide

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease1

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease1

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease1

Dosage Instructions

References

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease 1

Prevention of Atherothrombotic Events in patients with Coronary Artery Disease and Peripheral Artery Disease 1